Symetryx Corp, Ten Percent Owner at NeuBase Therapeutics, holds 0.00 shares in NeuBase Therapeutics (Ticker: NBSE). Most recently, Symetryx Corp Sold $282,445 shares of NeuBase Therapeutics on Sep 18, 2023 for an estimated value of 375.62K.
What is the percentage of profitable transactions made by Symetryx Corp?
The percentage of profitable transactions made by Symetryx Corp is ―.
What is the average return per transaction made by Symetryx Corp?
The average return per transaction made by Symetryx Corp is ―.
What stocks does Symetryx Corp hold?
Symetryx Corp holds: NBSE stocks.
What was Symetryx Corp’s latest transaction?
Symetryx Corp latest transaction was an Informative Sell of $375.62K.
What was Symetryx Corp's most profitable transaction?
Symetryx Corp’s most profitable transaction was an Informative Buy of NBSE stock on September 7, 2023. The return on the trade was -29.90%.
What is Symetryx Corp's role in NeuBase Therapeutics?
Symetryx Corp's role in NeuBase Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.